2901, 2025 Diatech Pharmacogenetics Expands Collaboration with Merck to Enhance Patient Access to Personalized Medicine in the Middle East and AfricaMehr erfahren
806, 2023 Oncology, the ‚microenvironment‘ is the super challenge of diagnostics Genomic tests are now used to create 50% of drugs. Aiming for 100%, Diatech creates the first expert board for new guidelinesMehr erfahren
2604, 2023 Diatech Pharmacogenetics announces Investment from TA to Fuel Strategic Growth InitiativesMehr erfahren
2810, 2015 Agena Bioscience and Diatech Pharmacogenetics Announce Plan to Launch Actionable, Targeted CE-IVD Marked Oncology Assays for Colon, Lung, and Melanoma TreatmentMehr erfahren
1206, 2014 Physiomics enters the personalized medicine market. Anticipated new collaboration with Diatech PharmacogeneticsMehr erfahren
802, 2012 Presentation of the 3rd annual course of Pharmacogenetics and Personalized MedicineMehr erfahren
